Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remifentanil and Flurbiprofen for ESWL Sedation
NCT01998217Phase 4Completed
- Sponsor
- Changhai Hospital
- Start
- Sep 2012
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of flurbiprofen in Pancreatic stone disease, sponsored by Changhai Hospital. Started Sep 2012; status: completed.
02
Drugs
flurbiprofen
03
Conditions
Pancreatic stone disease
Beyond the preview
Go deeper on NCT01998217.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01998217.